3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: November 5, 2012
Period of Report: October 31, 2012
Accession Number: 0001437749-12-010965

View Document ↗ View on SEC.gov ↗